Angiogenesis-related gene expression analysis in celiac disease

Autoimmunity

Volumn 45, Issue 3, 2012, Pages 264-270

  Castellanos Rubio, Ainara ^a   Caja, Sergio ^b   Irastorza, Iñaki ^c   Fernandez Jimenez, Nora ^a,d   Plaza Izurieta, Leticia ^a,d   Vitoria, Juan Carlos ^c,d   Maki, Markku ^b   Lindfors, Katri ^b   Bilbao, Jose Ramon ^a,d  

^a HOSPITAL DE CRUCES   (Spain)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^d Department of Genetics Animal Physiology and Physical Anthropology ^*  (Spain)

Author keywords

angiogenesis; celiac disease; gene expression; SNP; transglutaminase autoantibodies

Indexed keywords

APRIL PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HYPOXIA INDUCIBLE FACTOR 1ALPHA; JAGGED1; PROMYELOCYTIC LEUKEMIA PROTEIN; TRANSFORMING GROWTH FACTOR ALPHA;

ANG GENE; ANGIOGENESIS; ARTICLE; CASP8 GENE; CELIAC DISEASE; CHILD; CONTROLLED STUDY; DOWN REGULATION; ECGF1 GENE; FEMALE; GENE; GENE EXPRESSION; GENE FUNCTION; GENE INTERACTION; GENE REPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; GNA13 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE BIOPSY; INTESTINE CELL; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRESCHOOL CHILD; SCG1 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; STAB1 GENE; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION;

BIOPSY; CELIAC DISEASE; CELL LINE; CELLS, CULTURED; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INFANT; MALE; MODELS, STATISTICAL; NEOVASCULARIZATION, PATHOLOGIC; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84858632438     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2011.637531     Document Type: Article

References (20)

1. Stepniak D, Koning F. Celiac disease-sandwiched between innate and adaptive immunity. Hum Immunol 2006;67:460-468. (Pubitemid 43765609)
2. van Heel DA, Hunt K, Greco L, Wijmenga C. Genetics in coeliac disease. Best Pract Res Clin Gastroenterol 2005;19:323-339. (Pubitemid 40753755)
3. Jabri B, Sollid LM. Tissue-mediated control of immuno-pathology in coeliac disease. Nat Rev Immunol 2009;9(12):858-870.
4. Fesus L, Piacentini M. Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem Sci 2002;27(10):534-539. (Pubitemid 35279599)
5. Caja S, Myrsky E, Korponay-Szabo IR, Nadalutti C, Sulic AM, et al. Inhibition of transglutaminase 2 enzymatic activity ameliorates the anti-angiogenic effects of coeliac disease autoantibodies. Scand J Gastroenterol 2010;45(4):421-427.
6. Castellanos-Rubio A, Martin-Pagola A, Santín I, Hualde I, Aransay AM, Castaño L, et al. Combined functional and positional gene information for the identification of susceptibility variants in celiac disease. Gastroenterology 2008;134(3):738-746. (Pubitemid 351312722)
7. Castellanos-Rubio A, Santin I, Martin-Pagola A, Irastorza I, Castaño L, Vitoria JC, et al. Long-term and acute effects of gliadin on small intestine of patients on potentially pathogenic networks in celiac disease. Autoimmunity 2010;43(2):131-139.
8. Myrsky E, Caja S, Simon-Vecsei Z, Korponay-Szabo IR, Nadalutti C, Collighan R, et al. Celiac disease IgA modulates vascular permeability in vitro through the activity of transglutaminase 2 and RhoA. Cell Mol Life Sci 2009;66(20):3375-3385.
9. Myrsky E, Syrjänen M, Korponay-Szabo IR, Mäki M, Kaukinen K, Lindfors K. Altered small-bowel mucosal vascular network in untreated coeliac disease. Scand J Gastroenterol 2009;44(2):162-167.
10. Halttunen T, Marttinen A, Rantala I, Kainulainen H, MäkiM. Fibroblasts and transforming growth factor beta induce organization and differentiation of T84 human epithelial cells. Gastroenterology 1996;111(5):1252-1262. (Pubitemid 26362250)
11. Martin-Pagola A, Ortiz L, Perez de Nanclares G, Vitoria JC, Castaño L, Bilbao JR. Analysis of the expression of MICA in small intestinal mucosa of patients with celiac disease. J Clin Immunol 2003;23(6):498-503. (Pubitemid 38177670)
12. van HeelDA, Franke L, Hunt KA, Gwilliam R, Zhernakova A, Inouye M, et al. A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat Genet 2007;39(7):827-829. (Pubitemid 47014494)
13. Ruckhäberle E, Karn T, Engels K, Turley H, Hanker L, Müller V, et al. Prognostic impact of thymidine phosphorylase expression in breast cancer comparison of microarray and immunohistochemical data. Eur J Cancer 2010;46(3):549-557.
14. Xiao Y, Motomura S, Podack ER. APRIL (TNFSF13) regulates collagen-induced arthritis, IL-17 production and Th2 response. Eur J Immunol 2008;38(12):3450-3458.
15. Briani C, Samaroo D, Alaedini A. Celiac disease: from gluten to autoimmunity. Autoimmun Rev 2008;7(8):644-650.
16. Castellanos-Rubio A, Santin I, Irastorza I, Castaño L, Vitoria JC, Bilbao JR. TH17 (and TH1) signatures of intestinal biopsies of CD patients in response to gliadin. Autoimmunity 2009;42(1):69-73.
17. Vannay A, Sziksz E, Prókai A, Veres G, Molnár K, Szakál DN, et al. Increased expression of hypoxia-inducible factor 1alpha in coeliac disease. Pediatr Res 2010;68(2):118-122.
18. Park SY, Jung MY, Lee SJ, Kang KB, Gratchev A, Riabov V, et al. Stabilin-1 mediates phosphatidylserine-dependent clearance of cell corpses in alternatively activated macro-phages. J Cell Sci 2009;122(18):3365-3373.
19. Jones RA, Kotsakis P, Johnson TS, Chau DY, Ali S, Melino G, et al. Matrix changes induced by transglutaminase 2 lead to inhibition of angiogenesis and tumor growth. Cell Death Differ 2006;13(9):1442-1453. (Pubitemid 44210348)
20. Grötzinger T, Sternsdorf T, Jensen K, Will H. Interferon-modulated expression of genes encoding the nuclear-dot-associated proteins Sp100 and promyelocytic leukemia protein (PML). Eur J Biochem 1996;238(2):554-560. (Pubitemid 26191163)